Metrikler
Yayın
221
Açık Erişim
66
BM Sürdürülebilir Kalkınma Amaçları
Eğitim Bilgileri
1996 - 1999
1996 - 1999Tıpta Yandal Uzmanlık
Hacettepe Üniversitesi, Tıp Fakültesi, Hematoloji, Türkiye
1991 - 1996
1991 - 1996Tıpta Uzmanlık
Hacettepe Üniversitesi, Tıp Fakültesi, İç Hastalıkları, Türkiye
1984 - 1991
1984 - 1991Lisans
Hacettepe Üniversitesi, Tıp Fakültesi, Türkiye
Yabancı Diller
C1 İleri
C1 İleriİngilizce
Araştırma Alanları
Tıp
Sağlık Bilimleri
Dahili Tıp Bilimleri
İç Hastalıkları
Hematoloji
Akademik Faaliyetlere Dayalı Araştırma Alanları
Avesis Araştırma Alanları
WoS Araştırma Alanları
Scopus Araştırma Alanları
Akademik Ünvanlar / Görevler
2000 - Devam Ediyor
2000 - Devam EdiyorProf. Dr.
Hacettepe Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
Yönetimsel Görevler
2015 - Devam Ediyor
2015 - Devam EdiyorAnabilim/Bilim Dalı Başkanı
Hacettepe Üniversitesi, Hacettepe Tıp Fakültesı
2015 - Devam Ediyor
2015 - Devam EdiyorAnabilim/Bilim Dalı Başkanı
Hacettepe Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
Akademi Dışı Deneyim
2000 - Devam Ediyor
2000 - Devam EdiyorÖğretim Üyesi
Hacettepe Tıp Fakültesi İç Hastalıkları Anabilim Dalı Hematoloji Ünitesi, Öğretim Üyesi
1991 - 1996
1991 - 1996Araştırma Görevlisi
Hacettepe Tıp Fakültesi İç Hastalıkları Anabilim Dalı Hematoloji Ünitesi, Araştırma Görevlisi
1991 - 1996
1991 - 1996Araştırma Görevlisi
Hacettepe Tıp Fakültesi İç Hastalıkları Anabilim Dalı, Araştırma Görevlisi
Yönetilen Tezler
2006
2006Doktora
Herediter trombosit fonksiyon bozukluğunda görülen ağız içi bulguların klinik olarak incelenmesi
BÜYÜKAŞIK Y.
M.GÜNGÖR(Öğrenci)
Makaleler
Tümü (160)
SCI-E, SSCI, AHCI (149)
SCI-E, SSCI, AHCI, ESCI (157)
ESCI (8)
Scopus (153)
TRDizin (57)
Diğer Yayınlar (1)
2024
20241. Invasive fungal infections in patients with acute leukemia: A retrospective cohort study at a tertiary-care hospital
Alkan A., BÜYÜKAŞIK Y., UZUN Ö., DEMİR A. U., ÇÖPLÜ L.
MEDICINE
, cilt.103, sa.40, 2024 (SCI-Expanded, Scopus)
2024
20242. An Institutional Febrile Neutropenia Protocol Improved the Antibacterial Treatment and Encouraged the Development of a Computerized Clinical Decision Support System
TAŞ Z., METAN G., TELLİ DİZMAN G., Yavuz E., DİZDAR Ö., BÜYÜKAŞIK Y., et al.
ANTIBIOTICS-BASEL
, cilt.13, sa.9, 2024 (SCI-Expanded, Scopus)
2024
20243. The effect of prognostic features of patients with chronic lymphocytic leukemia on overall survival and treatment-free survival: A single-center experience
Alayvaz Aslan N., BÜYÜKAŞIK Y., SAYINALP N.
Journal of Experimental and Clinical Medicine (Turkey)
, cilt.41, sa.1, ss.125-131, 2024 (Scopus)
2023
20234. Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO Registry
Duran E., Ozturk Z. O., BİLGİN E., BÜYÜKAŞIK Y., DİZDAR Ö., Yardimci G. K., et al.
Rheumatology and Therapy
, cilt.10, sa.4, ss.969-981, 2023 (SCI-Expanded, Scopus)
2023
20235. Unmet clinical needs and challenges in the management of acute leukemia in Turkey: a modified Delphi study
Arat M., ALACACIOĞLU İ., Bolaman A. Z., BÜYÜKAŞIK Y., Cagirgan S., GÜVENÇ B., et al.
Future oncology (London, England)
, cilt.19, sa.14, ss.975-982, 2023 (SCI-Expanded, Scopus)
2023
20236. Downregulation of Stearoyl-CoA Desaturase 1 (SCD-1) Promotes Resistance to Imatinib in Chronic Myeloid Leukemia
Gunes B. A., Hekmatshoar Y., ÖZKAN T., Bozkurt S., AYDOS O. S., Buyukasik Y., et al.
Mediterranean Journal of Hematology and Infectious Diseases
, cilt.15, sa.1, 2023 (SCI-Expanded, Scopus)
2023
20237. A single-center experience of haploidentical stem cell transplantation in hematological malignancies
MALKAN Ü. Y., GÖKER H., DEMİROĞLU H., Tekin F., Akdemir B., ALADAĞ KARAKULAK E., et al.
Turkish Journal of Medical Sciences
, cilt.53, sa.1, ss.352-359, 2023 (SCI-Expanded, Scopus, TRDizin)
2022
20228. Hepatitis E Virus Prevalence and Associated Risk Factors in High-Risk Groups: A Cross-Sectional Study
BALABAN H. Y., ASLAN A. T., AKDOĞAN KITTANA F. N., ALP A., DAĞ O., AYAR Ş. N., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.33, sa.7, ss.615-624, 2022 (SCI-Expanded, Scopus, TRDizin)
2022
20229. Adenosine Deaminase Type II Deficiency: Severe Chronic Neutropenia, Lymphoid Infiltration in Bone Marrow, and Inflammatory Features.
SÜLEYMAN M., TAN Ç., ÜNER A., Inkaya C., Aytac Ş. S., BÜYÜKAŞIK Y., et al.
Immunological investigations
, cilt.51, sa.3, ss.558-566, 2022 (SCI-Expanded, Scopus)
2022
202210. Improving Survival Besides the High Early Mortality Rate in Acute Promyelocytic Leukemia
Malkan Ü. Y., Koca E., BÜYÜKAŞIK Y.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.32, sa.1, ss.1-7, 2022 (SCI-Expanded, Scopus, TRDizin)
2022
202211. Hematopoietic Adverse Events Associated with BNT162b2 mRNA Covid-19 Vaccine
Erdogdu B., ÇINAR O. E., Malkan Ü. Y., AKSU S., DEMİROĞLU H., BÜYÜKAŞIK Y., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.32, sa.1, ss.65-67, 2022 (SCI-Expanded, Scopus, TRDizin)
2022
202212. Covid-19 Related Fatality and Risk Factors in Multiple Myeloma: A Multicenter Cohort Study
KARADENİZ M., GÖKER H., Aydin O., Turgut M., MALKAN Ü. Y., Sener E., et al.
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
, cilt.32, sa.4, ss.209-213, 2022 (SCI-Expanded, Scopus, TRDizin)
2022
202213. Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem celltransplantation
KARATAŞ A., GÖKER H., DEMİROĞLU H., MALKAN Ü. Y., Velet M., ÇINAR O. E., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.52, sa.2, ss.413-419, 2022 (SCI-Expanded, Scopus, TRDizin)
2022
202214. Real-Life Experience Regarding Clinical Characteristics and Treatment Outcome in Non-Cutaneous Peripheral T-Cell Lymphomas: A Multicenter Study of the Turkish Hematology Research and Education Group (ThREG)
Kayikci O., MEHTAP Ö., Sari I., DEMİRKAN F., Beyan C., ÇETİN G., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.39, sa.3, ss.170-177, 2022 (SCI-Expanded, Scopus, TRDizin)
2021
202115. Long-term results of allogeneic peripheral blood hematopoietic stem cell transplantation for severe aplastic anemia
ALADAĞ KARAKULAK E., GÖKER H., DEMİROĞLU H., AKSU S., SAYINALP N., HAZNEDAROĞLU İ. C., et al.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.60, sa.2, 2021 (SCI-Expanded, Scopus)
2021
202116. Four-Dimensional Echocardiographic Evaluation of Left Ventricular Systolic Functions in Patients with Chronic Myeloid Leukaemia Receiving Tyrosine Kinase Inhibitors
KARAKULAK U. N., ALADAĞ KARAKULAK E., HEKİMSOY V., ŞAHİNER M. L., KAYA E. B., ÖZER N., et al.
CARDIOVASCULAR TOXICOLOGY
, cilt.21, sa.3, ss.216-223, 2021 (SCI-Expanded, Scopus)
2021
202117. Allogeneic Hematopoietic Stem-Cell Transplantation Improves Disease-Free Survival Compared to Pediatric-Inspired Berlin-Frankfurt-Munster Chemotherapy in Adult Acute Lymphoblastic Leukemia
ALADAĞ KARAKULAK E., Aktimur S. H., Aydin O., DEMİROĞLU H., BÜYÜKAŞIK Y., AKSU S., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, cilt.21, sa.3, ss.147-153, 2021 (SCI-Expanded, Scopus)
2021
202118. Prediction of Stem Cell Mobilization Failure in Patients with Hodgkin and Non-Hodgkin Lymphoma
DEMİROĞLU H., Ciftciler R., BÜYÜKAŞIK Y., GÖKER H.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.38, sa.3, ss.204-210, 2021 (SCI-Expanded, Scopus, TRDizin)
2021
202119. Assessment of ST2 and Reg3a levels in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
ALADAĞ KARAKULAK E., DEMİROĞLU H., Malkan Ü. Y., Akman U., GÖKER H., BÜYÜKAŞIK Y.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.51, sa.1, ss.355-358, 2021 (SCI-Expanded, Scopus, TRDizin)
2021
202120. Central nervous system involvement in patients with acute myeloid leukemia
YAŞAR H. A., ÇINAR O. E., Koylu N. Y., BARIŞTA İ., GÖKER H., BÜYÜKAŞIK Y.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.51, sa.5, ss.2351-2356, 2021 (SCI-Expanded, Scopus, TRDizin)
2021
202121. Evaluation of Prognostic Significance of the International Staging System According to Glomerular Filtration Rate in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation
Ciftciler R., GÖKER H., DEMİROĞLU H., HAZNEDAROĞLU İ. C., SAYINALP N., AKSU S., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.38, sa.1, ss.33-40, 2021 (SCI-Expanded, Scopus, TRDizin)
2021
202122. Effect of Salvage Chemotherapy Before Donor Lymphocyte Infusion in Patients With Relapse After Allogeneic Hematologic Stem Cell Transplantation
ALADAĞ KARAKULAK E., GÖKER H., BÜYÜKAŞIK Y., DEMİROĞLU H.
TRANSPLANTATION PROCEEDINGS
, cilt.53, sa.1, ss.391-395, 2021 (SCI-Expanded, Scopus)
2021
202123. Comparison of Risk Scoring Systems in HLA-Matched Related Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study
ALADAĞ KARAKULAK E., DEMİROĞLU H., BÜYÜKAŞIK Y., GÖKER H.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.38, sa.2, ss.138-144, 2021 (SCI-Expanded, Scopus, TRDizin)
2021
202124. Comparison of single and double autologous stem cell transplantation in multiple myeloma patients
Malkan Ü. Y., DEMİROĞLU H., BÜYÜKAŞIK Y., KARATAŞ A., ALADAĞ KARAKULAK E., GÖKER H.
OPEN MEDICINE
, cilt.16, sa.1, ss.192-197, 2021 (SCI-Expanded, Scopus)
2020
202025. Leukocytoclastic vasculitis as a previously unreported paraneoplastic manifestation of acute lymphoblastic leukemia in adults
Ismayilov R., Haziyev T., Ozdemir D. A., Saglam A., BÜYÜKAŞIK Y.
JOURNAL OF HEMATOPATHOLOGY
, cilt.13, sa.4, ss.265-268, 2020 (SCI-Expanded, Scopus)
2020
202026. Real-life outcomes of unselected acute promyelocytic leukemia patients: a single-center 14-year experience
Akcay O. F., YETER H. H., BÜYÜKAŞIK Y.
ROMANIAN JOURNAL OF INTERNAL MEDICINE
, cilt.58, sa.3, ss.138-145, 2020 (ESCI, Scopus)
2020
202027. Real-life outcomes of unselected acute promyelocytic leukemia patients: a single-center 14-year experience
AKÇAY Ö. F., YETER H. H., BÜYÜKAŞIK Y.
ROMANIAN JOURNAL OF INTERNAL MEDICINE = REVUE ROUMAINE DE MEDECINE INTERNE
, cilt.58, sa.3, ss.138-145, 2020 (ESCI, Scopus)
2020
202028. A unique mutation in the L ferritin coding sequence associated with low serum ferritin level in the presence of normal values of other iron parameters
Ciftciler R., Yilmaz E., BÜYÜKAŞIK Y.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.59, sa.4, 2020 (SCI-Expanded, Scopus)
2020
202029. Cardiac adverse events during stem cell transplantation for hematological malignancies: A single centre experience
ALADAĞ KARAKULAK E., DEMİROĞLU H., BÜYÜKAŞIK Y., KARAKULAK U. N., Tekin F., AKSU S., et al.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.59, sa.2, 2020 (SCI-Expanded, Scopus)
2020
202030. The experience of allogeneic hematopoietic stem cell transplantation in a patient with X-linked adrenoleukodystrophy
Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., TOPÇU M., Gevher N., DEMİROĞLU H.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.59, sa.1, 2020 (SCI-Expanded, Scopus)
2020
202031. Predictive factors for stem cell mobilization failure in multiple myeloma patients: A single center experience
GÖKER H., Ciftciler R., DEMİROĞLU H., Turgut M., SAYINALP N., Haznedaroglu I. C., et al.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.59, sa.1, 2020 (SCI-Expanded, Scopus)
2020
202032. Impact of ABO blood group incompatibility on the outcomes of allogeneic hematopoietic stem cell transplantation
Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., KARAAĞAÇ AKYOL T., AKSU S., Tekin F., et al.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.59, sa.1, 2020 (SCI-Expanded, Scopus)
2020
202033. The comparison of bone marrow kinetics between patients with acute myeloid leukemia and acute promyelocytic leukemia after induction chemotherapy
Ciftciler R., HAZNEDAROĞLU İ. C., Ozcebe O., AKSU S., SAYINALP N., GÖKER H., et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
, cilt.42, sa.1, ss.17-21, 2020 (SCI-Expanded, Scopus)
2020
202034. Splenic Marginal Zone Lymphoma in Turkey: Association with Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Possible Prognostic Factor - A Multicenter Cohort Study
OKAY M., Aslan T., Ozdemir E., ÜNER A., Saglam A., Gungor E., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.37, sa.2, ss.84-90, 2020 (SCI-Expanded, Scopus, TRDizin)
2020
202035. Patterns of Hydroxyurea Prescription and Use in Routine Clinical Management of Polycythemia Vera: A Multicenter Chart Review Study
BÜYÜKAŞIK Y., ALİ R., Turgut M., SAYDAM G., Yavuz S., ÜNAL A., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.37, sa.3, ss.177-185, 2020 (SCI-Expanded, Scopus, TRDizin)
2020
202036. Comparison of bortezomib-cyclophosphamide-dexametha-sone versus bortezomib-dexamethasone based regimens in newly diagnosed multiple myeloma patients
Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., SAYINALP N., HAZNEDAROĞLU İ. C., AKSU S., et al.
HEMATOLOGY REPORTS
, cilt.12, sa.1, 2020 (ESCI, Scopus)
2020
202037. Evaluation of the Survival Outcomes of Multiple Myeloma Patients According to Their Plasmacytoma Presentation at Diagnosis
Ciftciler R., GÖKER H., DEMİROĞLU H., AKSU S., SAYINALP N., HAZNEDAROĞLU İ. C., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.37, sa.4, ss.256-262, 2020 (SCI-Expanded, Scopus, TRDizin)
2020
202038. The Impact of Early Versus Late Platelet and Neutrophil Recovery after Induction Chemotherapy on Survival Outcomes of Patients with Acute Myeloid Leukemia
Ciftciler R., HAZNEDAROĞLU İ. C., SAYINALP N., Ozcebe O., AKSU S., DEMİROĞLU H., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.37, sa.2, ss.116-120, 2020 (SCI-Expanded, Scopus, TRDizin)
2019
201939. Impact of Time Between Induction Chemotherapy and Complete Remission on Survival Outcomes in Patients With Acute Myeloid Leukemia
Ciftciler R., DEMİROĞLU H., HAZNEDAROĞLU İ. C., SAYINALP N., AKSU S., Ozcebe O., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, cilt.19, sa.11, ss.729-734, 2019 (SCI-Expanded, Scopus)
2019
201940. SECONDARY MALIGNANCIES IN PATIENTS WITH MULTIPLE MYELOMA
ALADAĞ KARAKULAK E., BÜYÜKAŞIK Y., DEMİROĞLU H., AKSU S., GÖKER H.
AMERICAN JOURNAL OF HEMATOLOGY
, cilt.94, 2019 (SCI-Expanded, Scopus)
2019
201941. Impact of Pre-transplant and Post-transplant Remission Status of Patients on Survival in Newly Diagnosed Multiple Myeloma
Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., ALADAĞ KARAKULAK E., DEMİROĞLU H.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
, cilt.35, sa.4, ss.655-661, 2019 (SCI-Expanded, Scopus)
2019
201942. Mantle cell lymphoma: a Turkish Multi-Center Study
OKAY M., MELETLİ Ö., KELKİTLİ E., Malkan Ü. Y., Turgut M., BÜYÜKAŞIK Y., et al.
JOURNAL OF BUON
, cilt.24, sa.5, ss.2084-2089, 2019 (SCI-Expanded, Scopus)
2019
201943. Determining the frequency of iron overload at diagnosis in de novo acute myeloid leukemia patients with multilineage dysplasia or myelodysplasia-related changes: a case control study
Yavuz B., Aydin S., Bozkur S., ÜNER A., BÜYÜKAŞIK Y.
JOURNAL OF HEMATOPATHOLOGY
, cilt.12, sa.3, ss.135-141, 2019 (SCI-Expanded, Scopus)
2019
201944. Severe cytopenia related with the concomitant use of imiquimod and hydroxyurea
GÜLSEREN BÜYÜKDOĞAN D., ELÇİN G., BÜYÜKAŞIK Y.
DERMATOLOGIC THERAPY
, 2019 (SCI-Expanded, Scopus)
2019
201945. Myeloid maturation potentiates STAT3-mediated atypical IFN-gamma signaling and upregulation of PD-1 ligands in AML and MDS
Yoyen-Ermis D., Tunali G., Tavukcuoglu E., Horzum U., Ozkazanc D., Sutlu T., et al.
SCIENTIFIC REPORTS
, cilt.9, 2019 (SCI-Expanded, Scopus)
2019
201946. Ghosal hematodiaphyseal dysplasia with autoimmune anemia in two adult siblings
Ciftciler R., BÜYÜKAŞIK Y., Saglam E. A., HAZNEDAROĞLU İ. C.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.58, sa.4, ss.449-452, 2019 (SCI-Expanded, Scopus)
2019
201947. TKI-Related Platelet Dysfunction Does Not Correlate With Bleeding in Patients With Chronic Phase-Chronic Myeloid Leukemia With Complete Hematological Response
Sener Y., OKAY M., Aydin S., BÜYÜKAŞIK Y., AKBIYIK F., DİKMEN Z. G.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
, cilt.25, 2019 (SCI-Expanded, Scopus)
2019
201948. Impact of bone marrow plasma cells percentage on survival at diagnosis and pre-transplant period in newly diagnosed multiple myeloma: Experience of a single center from Turkey
Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., ALADAĞ KARAKULAK E., Saglam E. A., DEMİROĞLU H.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.58, sa.3, ss.313-317, 2019 (SCI-Expanded, Scopus)
2019
201949. CYTOGENETIC ANOMALIES IN MULTIPLE MYELOMA PATIENTS: A SINGLE CENTER STUDY
BOZKURT S., BÜYÜKAŞIK Y., DEMİROĞLU H., ALADAĞ KARAKULAK E., OKAY M., KARATAŞ A., et al.
Genetics and Application , cilt.3, sa.1, ss.51-56, 2019 (Hakemli Dergi)
2019
201950. Impact of Blood Count Recovery-based Complete Remission Before Allogeneic Hematopoietic Stem Cell Transplantation on Survival in Patients With Acute Myeloid Leukemia
Ciftciler R., DEMİROĞLU H., BÜYÜKAŞIK Y., AKSU S., Gokei H.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, cilt.19, sa.5, 2019 (SCI-Expanded, Scopus)
2019
201951. Extramedullary relapses of acute leukemias after allogeneic hematopoietic stem cell transplantation: clinical features, cumulative incidence, and risk factors
Gunes G., GÖKER H., DEMİROĞLU H., Malkan Ü. Y., BÜYÜKAŞIK Y.
BONE MARROW TRANSPLANTATION
, cilt.54, sa.4, ss.595-600, 2019 (SCI-Expanded, Scopus)
2019
201952. Efficacy and Feasibility of Allogeneic Hematopoietic Stem-Cell Transplantation in the Treatment of Refractory Acute Myeloid Leukemia
Ciftciler R., DEMİROĞLU H., BÜYÜKAŞIK Y., ALADAĞ KARAKULAK E., AKSU S., HAZNEDAROĞLU İ. C., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, cilt.19, sa.3, ss.177-182, 2019 (SCI-Expanded, Scopus)
2019
201953. Acute Lymphoblastic Leukemia in Routine Practice: A Turkish Multicenter Study
Ciftciler R., Sevindik O. G., Tekgunduz A. I. E., ERKURT M. A., VURAL F., TURGUT B., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.36, sa.3, ss.169-177, 2019 (SCI-Expanded, Scopus, TRDizin)
2019
201954. Fibrosis Development, Leukemic Transformation and Secondary Malignancies Complicating the Clinical Course of Essential Thrombocythemia
Ciftciler R., AKSU S., Malkan Ü. Y., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.29, sa.1, ss.14-21, 2019 (SCI-Expanded, Scopus, TRDizin)
2019
201955. The factors affecting early death in newly diagnosed APL patients
Ciftciler R., HAZNEDAROĞLU İ. C., AKSU S., Ozcebe O., SAYINALP N., Malkan Ü. Y., et al.
OPEN MEDICINE
, cilt.14, sa.1, ss.647-652, 2019 (SCI-Expanded, Scopus)
2019
201956. EBV-Related Diffuse Large B-Cell Lymphoma in a Patient with Angioimmunoblastic T-Cell Lymphoma
ŞİMŞEK C., BOSTANKOLU B., ÖZOĞUL E., Ayhan A. S., ÜNER A., BÜYÜKAŞIK Y.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.36, sa.1, ss.57-59, 2019 (SCI-Expanded, Scopus, TRDizin)
2019
201957. Comparison of Myeloablative Versus Reduced-Intensity Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia: A Cohort Study
Ciftciler R., GÖKER H., DEMİROĞLU H., ALADAĞ KARAKULAK E., AKSU S., HAZNEDAROĞLU İ. C., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.36, sa.2, ss.88-96, 2019 (SCI-Expanded, Scopus, TRDizin)
2019
201958. Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma
OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., Malkan Ü. Y., Ciftciler R., ALADAĞ KARAKULAK E., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.49, sa.4, ss.985-992, 2019 (SCI-Expanded, Scopus, TRDizin)
2019
201959. Unclassifiable non-CML classical myeloproliferative diseases with microcytosis: findings indicating diagnosis of polycythemia vera masked by iron deficiency
ALADAĞ KARAKULAK E., AKSU S., DEMİROĞLU H., SAYINALP N., GÖKER H., HAZNEDAROĞLU İ. C., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.49, sa.5, ss.1560-1563, 2019 (SCI-Expanded, Scopus, TRDizin)
2019
201960. Indications and outcomes of splenectomy for hematological disorders
Ciftciler R., Pasayeva A., AKSU S., Ozcebe O., SAYINALP N., Malkan Ü. Y., et al.
OPEN MEDICINE
, cilt.14, sa.1, ss.491-496, 2019 (SCI-Expanded, Scopus)
2019
201961. Impact of pre-transplant bone marrow blast percentage on survival in acute myeloid leukemia patients
Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., Malkan Ü. Y., Saglam E. A., DEMİROĞLU H.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
, cilt.12, sa.7, ss.9288-9294, 2019 (SCI-Expanded)
2018
201862. Effect of postremission high dose cytarabine-based consolidation chemotherapy before allogenic stem cell transplantation in outcomes of acute myeloid leukemia patients
CIFTCILER R., DEMİROĞLU H., BÜYÜKAŞIK Y., OKAY M., AKSU S., Sayinalp N., et al.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.57, sa.6, ss.752-755, 2018 (SCI-Expanded, Scopus)
2018
201863. Evaluation of Secondary Malignancies in Chronic Lymphocytic Leukemia
DEMİROĞLU H., SAYINALP N., GÖKER H., BÜYÜKAŞIK Y., ÖZCEBE O. İ., HAZNEDAROĞLU İ. C., et al.
Journal of Global Oncology , ss.205, 2018 (ESCI)
2018
201864. Hemophagocytic Lymphohistiocytosis in Adults: Low Incidence of Primary Neoplasm as a Trigger in a Case Series from Turkey
ARSLAN F., Alp Ş., BÜYÜKAŞIK Y., Ozkan M. C., ŞAHİN F., Basaran S., et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
, cilt.10, 2018 (SCI-Expanded, Scopus)
2018
201865. Monoclonal gammopathy of renal significance presenting as monotypic plasma cell interstitial nephritis in two patients with Sjogren's syndrome
Saglam A., Balaban S., YILDIRIM T., ERDEM Y., ÜNER A., BÜYÜKAŞIK Y.
VIRCHOWS ARCHIV
, cilt.472, sa.5, ss.865-869, 2018 (SCI-Expanded, Scopus)
2018
201866. Hematopoietic stem cell transplantation in geriatric patients in Turkey
GÖKER H., KELKİTLİ E., BÜYÜKAŞIK Y., DEMİROĞLU H.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.57, sa.2, ss.159-162, 2018 (SCI-Expanded, Scopus)
2018
201867. Polycythemia vera: diagnosis, clinical course, and current management
BÜYÜKAŞIK Y., ALİ R., Cem A. R., Turgut M., Yavuz S., SAYDAM G.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.48, sa.4, ss.698-710, 2018 (SCI-Expanded, Scopus, TRDizin)
2018
201868. Pediatric Chemotherapeutic Regimen (BFM-95) is Superior for Overall Survival in Adult Acute Lymphoblastic Leukemia
KARCIOĞLU A. M., OKAY M., BÜYÜKAŞIK Y., Malkan Ü. Y., SAYINALP N., DEMİROĞLU H., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.28, sa.4, ss.254-260, 2018 (SCI-Expanded, Scopus, TRDizin)
2017
201769. The impact of chemo/immune therapy-related cytopenias on the clinical course of chronic lymphoid leukemia
Malkan Ü. Y., OKAY M., HAZNEDAROĞLU İ. C., GÜNEŞ G., Aslan N. A., ÖZCEBE O. İ., et al.
LEUKEMIA & LYMPHOMA
, cilt.58, ss.96, 2017 (SCI-Expanded)
2017
201770. Sole Infrequent Karyotypic Aberration Trisomy 6 in a Patient with Acute Myeloid Leukemia and Breast Cancer in Remission
AYDIN M. S., BOZKURT S., GÜNEŞ G., Malkan Ü. Y., Aslan T., ETGÜL S., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.34, sa.1, ss.103-104, 2017 (SCI-Expanded, Scopus, TRDizin)
2017
201771. Assessment of the HScore for reactive haemophagocytic syndrome in patients with rheumatic diseases
Batu E. D., Erden A., Seyhoglu E., KILIÇ L., BÜYÜKAŞIK Y., KARADAĞ Ö., et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
, cilt.46, sa.1, ss.44-48, 2017 (SCI-Expanded, Scopus)
2017
201772. TP53 Staining in Tissue Samples of Chronic Lymphocytic Lymphoma Cases: An Immunohistochemical Survey of 51 Cases
Kulac I., Demir C., BÜYÜKAŞIK Y., Kutluk T., ÜNER A.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.34, sa.1, ss.34-39, 2017 (SCI-Expanded, Scopus, TRDizin)
2016
201673. Functional exhaustion of CD4(+) T cells induced by co-stimulatory signals from myeloid leukaemia cells
Özkazanç D., Yöyen-Ermiş D., Tavukçuoğlu E., BÜYÜKAŞIK Y., ESENDAĞLI G.
IMMUNOLOGY
, cilt.149, sa.4, ss.460-471, 2016 (SCI-Expanded, Scopus)
2016
201674. Investigation of hemophagocytic lymphohistiocytosis in severe sepsis patients.
HALACLI B., Unver N., HALACLI S., CANPINAR H., ERSOY E., OCAL S., et al.
Journal of critical care
, cilt.35, ss.185-90, 2016 (SCI-Expanded, Scopus)
2016
201675. Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Daily Practice: A Multicenter Experience
Tekgunduz E., GÖKER H., KAYNAR L., SARI İ., Pala C., Dogu M. H., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, cilt.16, sa.5, ss.269-274, 2016 (SCI-Expanded, Scopus)
2016
201676. Retrospective analysis of adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic cell transplantation: A multicenter experience of daily practice
Tekgunduz E., KAYNAR L., GÖKER H., Kaya A. H., ERMİŞ TURAK E., ELİAÇIK E., et al.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.54, sa.1, ss.41-47, 2016 (SCI-Expanded, Scopus)
2016
201677. Chimeric antigen receptor T cell treatment in hematologic malignancies
GÖKER H., Malkan Ü. Y., DEMİROĞLU H., BÜYÜKAŞIK Y.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.54, sa.1, ss.35-40, 2016 (SCI-Expanded, Scopus)
2016
201678. The Impact of Jak1/Jak2 Inhibitor Ruxolitinib on the Spleen Size and Symptom Burden in Myeloproliferative Diseases
Aktimur S. H., Malkan U. Y., Eyupoglu D. N., HAZNEDAROĞLU İ. C., KELKİTLİ E., Atay H. M., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.26, sa.3, ss.153-158, 2016 (SCI-Expanded, Scopus, TRDizin)
2016
201679. Comparison of Myelodysplastic Syndrome Prognostic Scoring Systems
BEKTAŞ Ö., ÜNER A., ELİAÇIK E., Uz B., Isik A., ETGÜL S., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.33, sa.2, ss.119-126, 2016 (SCI-Expanded, Scopus, TRDizin)
2016
201680. The Impact of Variant Philadelphia Chromosome Translocations on the Clinical Course of Chronic Myeloid Leukemia
Eyupoglu D., BOZKURT S., Haznedaroglu I., BÜYÜKAŞIK Y., Guven D.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.33, sa.1, ss.60-65, 2016 (SCI-Expanded, Scopus, TRDizin)
2016
201681. A new risk scoring model for prediction of poor coronary collateral circulation in acute non-ST-elevation myocardial infarction
Ileri M., Guray U., Yetkin E., Gursoy H. T., Bayir P. T., Sahin D., et al.
CARDIOLOGY JOURNAL
, cilt.23, sa.1, ss.107-113, 2016 (SCI-Expanded, Scopus)
2016
201682. The Prognosis of Adult Burkitt's Cell Leukemia in Real-Life Clinical Practice
Malkan Ü. Y., GÜNEŞ G., GÖKER H., HAZNEDAROĞLU İ. C., Acar K., ELİAÇIK E., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.33, sa.4, ss.281-285, 2016 (SCI-Expanded, Scopus, TRDizin)
2016
201683. Venous ulcerations due to inherited fibrinogen disorder in two male siblings
Yildirim S. K., ELÇİN G., BÜYÜKAŞIK Y.
TURKDERM-ARCHIVES OF THE TURKISH DERMATOLOGY AND VENEROLOGY
, cilt.50, sa.3, ss.131-134, 2016 (ESCI, Scopus, TRDizin)
2016
201684. The Impact of Iron Overload on Transplant-Related Complications and Prognosis of Acute Leukemias
Malkan U. Y., GÜNEŞ G., ELİAÇIK E., HAZNEDAROĞLU İ. C., Yayar O., ETGÜL S., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.26, sa.1, ss.54-60, 2016 (SCI-Expanded, Scopus, TRDizin)
2016
201685. Expression Profiles of the Individual Genes Corresponding to the Genes Generated by Cytotoxicity Experiments with Bortezomib in Multiple Myeloma
GHASEMİ m., ALPSOY S., TÜRK TÜRK S., MALKAN Ü. Y., ATAKAN Ş., HAZNEDAROĞLU İ. C., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.33, sa.4, ss.286-292, 2016 (SCI-Expanded, Scopus, TRDizin)
2016
201686. Chronic liver diseases and iron: a concise review with emphasis on hypotransferrinemia and hypohepcidinemia
Buyukasik N. S., BÜYÜKAŞIK Y.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.46, sa.5, ss.1281-1291, 2016 (SCI-Expanded, Scopus, TRDizin)
2015
201587. High frequency of autonomous T-cell proliferation compatible with T-cell large granular lymphocytic leukemia in patients with cytopenia of unknown etiology
BEKTAŞ Ö., ÜNER A., Aydin S. M., ELİAÇIK E., Uz B., Isik A., et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY
, cilt.102, sa.2, ss.211-217, 2015 (SCI-Expanded, Scopus)
2015
201588. Optimizing mobilization strategies in difficult-to-mobilize patients: The role of plerixafor
GÖKER H., ETGÜL S., BÜYÜKAŞIK Y.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.53, sa.1, ss.23-29, 2015 (SCI-Expanded, Scopus)
2015
201589. Bone marrow fibrosis may be an effective independent predictor of the 'TKI drug response level' in chronic myeloid leukemia
ELİAÇIK E., Isik A., Aydin C., ÜNER A., AKSU S., SAYINALP N., et al.
HEMATOLOGY
, cilt.20, sa.7, ss.392-396, 2015 (SCI-Expanded, Scopus)
2015
201590. On the association between chronic myelomonocytic leukemia and immune thrombocytopenia: comments on the article by Hadjadj etal.
BÜYÜKAŞIK Y.
EUROPEAN JOURNAL OF HAEMATOLOGY
, cilt.94, sa.6, ss.558, 2015 (SCI-Expanded, Scopus)
2015
201591. Free Protein S Reference Ranges in Gravidas Without Hereditary and Acquired Thrombophilia
Basaran A., DEREN Ö., BÜYÜKAŞIK Y., Basaran M.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
, cilt.31, sa.2, ss.286-291, 2015 (SCI-Expanded, Scopus)
2015
201592. Pharmacobiological Approach for the Clinical Development of Ruxolitinib in Myeloproliferative Neoplasms
ELİAÇIK E., Isik A., AKSU S., ÜNER A., BÜYÜKAŞIK Y., SAYINALP N., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.32, sa.2, ss.163-167, 2015 (SCI-Expanded, Scopus, TRDizin)
2015
201593. Common variable immune deficiency associated Hodgkin's lymphoma complicated with EBV-linked hemophagocytic lymphohistiocytosis: a case report
Malkan Ü. Y., GÜNEŞ G., Aslan T., ETGÜL S., Aydin S., BÜYÜKAŞIK Y.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
, cilt.8, sa.8, ss.14203-14206, 2015 (SCI-Expanded, Scopus)
2015
201594. Rebound Thrombocytosis following Induction Chemotherapy Is an Independent Predictor of a Good Prognosis in Acute Myeloid Leukemia Patients Attaining First Complete Remission
Malkan Ü. Y., Gunes G., Isik A., Eliacik E., Etgul S., Aslan T., et al.
ACTA HAEMATOLOGICA
, cilt.134, sa.1, ss.32-37, 2015 (SCI-Expanded, Scopus)
2015
201595. The factors affecting early death after the initial therapy of acute myeloid leukemia
Malkan Ü. Y., GÜNEŞ G., ELİAÇIK E., HAZNEDAROĞLU İ. C., ETGÜL S., Aslan T., et al.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
, cilt.8, sa.12, ss.22564-22569, 2015 (SCI-Expanded, Scopus)
2015
201596. Clinicopathological associations of acquired erythroblastopenia
GÜNEŞ G., Malkan Ü. Y., YAŞAR H. A., ELİAÇIK E., HAZNEDAROĞLU İ. C., DEMİROĞLU H., et al.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
, cilt.8, sa.12, ss.22515-22519, 2015 (SCI-Expanded, Scopus)
2015
201597. Late Onset and Protracted Course of Steroid Refractory Chronic Graft-versus-Host Disease
GÜNEŞ G., DEMİROĞLU H., GÖKER H., Malkan Ü. Y., ELİAÇIK E., Yayar O., et al.
CASE REPORTS IN HEMATOLOGY
, 2015 (ESCI)
2015
201598. Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies
Kara O., Zarakolu P., AŞÇIOĞLU HAYRAN S., ETGÜL S., Uz B., BÜYÜKAŞIK Y., et al.
INFECTIOUS DISEASES
, cilt.47, sa.10, ss.686-693, 2015 (SCI-Expanded, Scopus)
2015
201599. Generic Imatinib Mesylate is as Effective as Original Glivec in the Clinical Management of CML
Malkan U. Y., AKSU S., Aktimur S. H., Atay H., Bektas O., BÜYÜKAŞIK Y., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.25, sa.4, ss.215-221, 2015 (SCI-Expanded, Scopus, TRDizin)
2014
2014100. Massive Life-Threatening Hemorrhages Due to Toxic Oral Intake of 3750 Mg Dabigatran Etexilate As a Suicide Attempt and the Clinical Management
GÜNEŞ G., Malkan Ü. Y., AKSU S., HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y., SAYINALP N., et al.
BLOOD
, cilt.124, sa.21, 2014 (SCI-Expanded, Scopus)
2014
2014101. Rebound Thrombocytosis Is an Independent Predictor of Good Prognosis in AML Patients Attaining First Complete Remission
Malkan Ü. Y., GÜNEŞ G., GÖKER H., ELİAÇIK E., Isik A., SAYINALP N., et al.
BLOOD
, cilt.124, sa.21, 2014 (SCI-Expanded, Scopus)
2014
2014102. Local Renin-Angiotensin System in Normal Hematopoietic and Multiple Myeloma-Related Progenitor Cells
Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Hatirnaz O., AKSU S., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.31, sa.2, ss.136-142, 2014 (SCI-Expanded, Scopus, TRDizin)
2014
2014103. Giant Hemophilic Pseudotumor of the Iliopsoas: Case Report
MALKAN Ü. Y., Gunes G., Eliacik E., ISIK A., AKSU S., ATİLLA B., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.24, sa.4, ss.286-288, 2014 (SCI-Expanded, Scopus, TRDizin)
2014
2014104. Acute in Vitro effects of ABS (Ankaferd Hemostat) on the Lymphoid Neoplastic Cells (B-CLL and RAJI Tumor Cell Lines)
AKALIN İ., Okur F. V., HAZNEDAROĞLU İ. C., SAYINALP N., AKSU S., BÜYÜKAŞIK Y., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.24, sa.4, ss.253-259, 2014 (SCI-Expanded, Scopus, TRDizin)
2014
2014105. An Immune Thrombocytopenic Purpura-Like Picture Preceding Chronic Myelomonocytic Leukemia: A Case Series and Review of the Literature
Albayrak M., ELİAÇIK E., KORUCU B., Isik A., GÜNEŞ G., AKSU S., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.24, sa.3, ss.213-216, 2014 (SCI-Expanded, Scopus, TRDizin)
2014
2014106. Vitamin B-12 Deficiency with the Absence of Anemia in Young and Middle-Aged Population
Kara A., Eliacik E., BÜYÜKAŞIK Y., ÖZCEBE O. İ., Haznedaroglu I., AKSU S., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.24, sa.3, ss.190-194, 2014 (SCI-Expanded, Scopus, TRDizin)
2013
2013107. Local hematopoietic renin-angiotensin system in myeloid versus lymphoid hematological neoplastic disorders
Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Ng O. H., BÜYÜKAŞIK Y., et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
, cilt.14, sa.4, ss.308-314, 2013 (SCI-Expanded, Scopus)
2013
2013108. Co-expression of t(5;17) and t(8;21) in a Case of Acute Promyelocytic Leukemia: Review of the Literature
Uz B., ELİAÇIK E., Isik A., AKSU S., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.30, sa.4, ss.400-404, 2013 (SCI-Expanded, Scopus, TRDizin)
2013
2013109. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: A single center experience
GÖKER H., Ozdemir E., UZ B., BÜYÜKAŞIK Y., Turgut M., SEREFHANOGLU S., et al.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.49, sa.3, ss.590-599, 2013 (SCI-Expanded, Scopus)
2013
2013110. The Impact of Eltrombopag Administration on the Clinical Course of Severe Refractory Fatal Acquired Aplastic Anemia
Isik A., ELİAÇIK E., HAZNEDAROĞLU İ. C., AKSU S., SAYINALP N., BÜYÜKAŞIK Y., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.30, sa.3, ss.328-330, 2013 (SCI-Expanded, Scopus, TRDizin)
2013
2013111. EUTOS CML prognostic scoring system predicts ELN-based 'event-free survival' better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate
Uz B., BÜYÜKAŞIK Y., Atay H., KELKİTLİ E., Turgut M., BEKTAŞ Ö., et al.
HEMATOLOGY
, cilt.18, sa.5, ss.247-252, 2013 (SCI-Expanded, Scopus)
2013
2013112. Long-term Follow-up Study in Budd-Chiari Syndrome Single-center Experience in 22 Years
HARMANCI Ö., KAV T., PEYNİRCİOĞLU B., BÜYÜKAŞIK Y., SÖKMENSÜER C., BAYRAKTAR Y.
JOURNAL OF CLINICAL GASTROENTEROLOGY
, cilt.47, sa.8, ss.706-712, 2013 (SCI-Expanded, Scopus)
2013
2013113. Long-Term Sustained Hemorrhage Due to Bone Marrow Biopsy Successfully Treated With Topical Ankaferd Hemostat in a Bleeding-Prone Patient With Secondary Amyloidosis
Uz B., SAİN GÜVEN G., Isik A., KUYUMCU M. E., BEKTAŞ Ö., ELİAÇIK E., et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
, cilt.19, sa.3, ss.338-340, 2013 (SCI-Expanded, Scopus)
2013
2013114. Prognostic importance of additional cytogenetic anomalies in chronic myeloid leukemia
BOZKURT S., Uz B., BÜYÜKAŞIK Y., BEKTAŞ Ö., Inanc A., GÖKER H., et al.
MEDICAL ONCOLOGY
, cilt.30, sa.1, 2013 (SCI-Expanded, Scopus)
2013
2013115. Renin-Angiotensin System (RAS) Expressions in Myeloid Leukemic Cell Lines
Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Hatirnaz Ng O., BÜYÜKAŞIK Y., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.23, sa.4, ss.264-268, 2013 (SCI-Expanded, Scopus, TRDizin)
2013
2013116. Bone Marrow Iron Staining is a Reliable Test for Elimination of Iron Deficiency Anemia Rather than its Diagnosis
Koca E., Cetiner D. A., BÜYÜKAŞIK Y., ÜNER A., SAYINALP N., HAZNEDAROĞLU İ. C., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.23, sa.4, ss.260-263, 2013 (SCI-Expanded, Scopus, TRDizin)
2013
2013117. Hyper-CVAD Regimen in Routine Management of Adult Acute Lymphoblastic Leukemia: A Retrospective Multicenter Study
BÜYÜKAŞIK Y., Acar K., Kelkitli E., UZ B., SEREFHANOGLU S., Ozdemir E., et al.
ACTA HAEMATOLOGICA
, cilt.130, sa.3, ss.199-205, 2013 (SCI-Expanded, Scopus)
2012
2012118. Are low-molecular-weight heparins appropriately dosed in patients with CKD stage 3 to 5?
YILDIRIM T., Kocak T., BÜYÜKAŞIK Y., Yilmaz R., Altun B., Erdem Y., et al.
BLOOD COAGULATION & FIBRINOLYSIS
, cilt.23, sa.8, ss.700-704, 2012 (SCI-Expanded, Scopus)
2012
2012119. Extremely high parathyroid hormone concentrations associated with pityriasis rubra pilaris and monoclonal gammopathy of unknown significance: A clinical dilemma
Tanriover M., Portakal O., Hapa A., Tekinel Y., DAĞDELEN S., BÜYÜKAŞIK Y., et al.
BONE
, cilt.51, sa.5, ss.847-850, 2012 (SCI-Expanded, Scopus)
2012
2012120. How do we collect better granulocyte?
Akyol T. K., Buyukasik Y., Aksu S., Ozcebe O. I.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.47, sa.1, ss.107-111, 2012 (SCI-Expanded, Scopus)
2012
2012121. Pre-operative flexion contracture determines the functional outcome of haemophilic arthropathy treated with total knee arthroplasty
ATİLLA B., ÇAĞLAR Ö., Pekmezci M., BÜYÜKAŞIK Y., TOKGÖZOĞLU A. M., ALPASLAN M.
HAEMOPHILIA
, cilt.18, sa.3, ss.358-363, 2012 (SCI-Expanded, Scopus)
2012
2012122. Giant Abdominopelvic Haematoma Arising from Ovulation in a Glanzmann's Thrombasthenia Patient with Platelet Refractoriness: Treatment with Surgery and Intra-Abdominal Tranexamic Acid
BÜYÜKAŞIK Y., BOYRAZ G., Selcuk I., BEKTAŞ Ö., TUNCER Z. S.
ACTA HAEMATOLOGICA
, cilt.128, sa.3, ss.154-157, 2012 (SCI-Expanded, Scopus)
2012
2012123. Unusual Extramedullary Recurrence and Renal Relapse Despite Complete Chimerysm after Allografting in Ph+ ALL
Serefhanoglu S., GÖKER H., BAYDAR D., ÜNER A., ARICI M., HAZNEDAROĞLU İ. C., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.22, sa.1, ss.46-50, 2012 (SCI-Expanded, Scopus, TRDizin)
2012
2012124. Effective Molecular Monitoring and the Proper Management of Pleural Effusion During the First-Line Dasatinib Administration in CML
AKSU S., BEKTAŞ Ö., Uz B., BÜYÜKAŞIK Y., SAYINALP N., Ozcebe O., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.22, sa.1, ss.1-7, 2012 (SCI-Expanded, Scopus, TRDizin)
2012
2012125. Elevated urinary angiotensinogen a marker of intrarenal renin angiotensin system in hypertensive renal transplant recipients: does it play a role in development of proteinuria in hypertensive renal transplant patients?
Kutlugun A. A., ALTUN B., BÜYÜKAŞIK Y., AKI F. T., TÜRKMEN E., Altindal M., et al.
TRANSPLANT INTERNATIONAL
, cilt.25, sa.1, ss.13-18, 2012 (SCI-Expanded, Scopus)
2011
2011126. Clinical investigation of oral findings in inherited disorders of platelet function
GÜNGÖR HATİPOĞLU M., Kansu O., BÜYÜKAŞIK Y.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.28, sa.4, ss.294-298, 2011 (SCI-Expanded, Scopus, TRDizin)
2011
2011127. Serum iron parameters in cirrhosis and chronic hepatitis: Detailed description
Buyukasik N. S., Nadir I., Akin F. E., Cakal B., KAV T., Ersoy O., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.22, sa.6, ss.606-611, 2011 (SCI-Expanded, Scopus, TRDizin)
2011
2011128. Eculizumab before and after allogeneic hematopoietic stem cell transplantation in a patient with paroxysmal nocturnal hemoglobinuria
GÖKER H., Uz B., BÜYÜKAŞIK Y., AKSU S., Haznedaroglu I., SAYINALP N., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.28, sa.3, ss.223-227, 2011 (SCI-Expanded, Scopus, TRDizin)
2011
2011129. Short and long term effects of granulocyte colony-stimulating factor during induction therapy in acute myeloid leukemia patients younger than 65: Results of a randomized multicenter phase III trial
BEKSAÇ M., ALİ R., Ozcelik T., ÖZCAN M., Ozcebe O., Bayik M., et al.
LEUKEMIA RESEARCH
, cilt.35, sa.3, ss.340-345, 2011 (SCI-Expanded, Scopus)
2011
2011130. Use of Second Generation Tyrosine Kinase Inhibitors for Second-Line Treatment of Chronic Myeloid Leukemia After Imatinib Failure
BÜYÜKAŞIK Y.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.21, sa.2, ss.4-9, 2011 (SCI-Expanded, Scopus, TRDizin)
2011
2011131. THE FACTORS INFLUENCING OVERALL SURVIVAL IN NEWLY DIAGNOSED ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS
Serefhanoglu S., BÜYÜKAŞIK Y., AKSU S., GÖKER H., SAYINALP N., Cetgner D., et al.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI
, cilt.74, sa.1, ss.7-12, 2011 (ESCI, TRDizin)
2011
2011132. Cutoff Level to Detect Heterozygous Alpha 1 Antitrypsin Deficiency in Turkish Population
ŞİMŞEK H., PINAR A., Altinbas A., Alp A., Balaban Y. H., BÜYÜKAŞIK Y., et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS
, cilt.25, sa.4, ss.296-299, 2011 (SCI-Expanded, Scopus)
2011
2011133. Identification of clinical and simple laboratory variables predicting responsible gastrointestinal lesions in patients with iron deficiency anemia
Serefhanoglu S., BÜYÜKAŞIK Y., Emmungil H., SAYINALP N., HAZNEDAROĞLU İ. C., GÖKER H., et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES
, cilt.8, sa.1, ss.30-38, 2011 (SCI-Expanded, Scopus)
2011
2011134. A Comparison of Jurkat Cell-Reactive Anti-T Lymphocyte Globulin and Fetal Anti-Thymocyte Globulin Preparations in the Treatment of Aplastic Anemia
Serefhanoglu S., Buyukasik Y., Purnak T., Goker H., Sayinalp N., Haznedaroglu I. C., et al.
MEDICAL PRINCIPLES AND PRACTICE
, cilt.20, sa.4, ss.341-344, 2011 (SCI-Expanded, Scopus)
2010
2010135. Clinical features and outcomes of 49 Turkish patients with acute promyelocytic leukemia who received ATRA and anthracyclines (PETHEMA protocol) therapy
SEREFHANOGLU S., BÜYÜKAŞIK Y., GÖKER H., SAYINALP N., HAZNEDAROĞLU İ. C., AKSU S., et al.
LEUKEMIA RESEARCH
, cilt.34, sa.12, 2010 (SCI-Expanded, Scopus)
2010
2010136. Increased serum vitamin B-12 levels are associated with adult-onset Still's disease with reactive macrophage activation syndrome
KALYONCU U., BÜYÜKAŞIK Y., AKDOĞAN A., KARADAĞ Ö., APRAŞ BİLGEN Ş. Ş., KİRAZ S., et al.
JOINT BONE SPINE
, cilt.77, sa.2, ss.131-134, 2010 (SCI-Expanded, Scopus)
2010
2010137. Chronic Myeloid Leukemia: Practical Issues in Diagnosis, Treatment and Follow-Up
BÜYÜKAŞIK Y., Haznedaroglu I. C., Ilhan O.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.20, sa.2, ss.1-12, 2010 (SCI-Expanded, Scopus, TRDizin)
2010
2010138. The Gray-Zone Concept, Suboptimal Response to Imatinib, Shall be Removed from the ELN-CML Recommendations
HAZNEDAROĞLU İ. C., Koca E., AKSU S., GÖKER H., SAYINALP N., BÜYÜKAŞIK Y., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.20, sa.2, ss.25-26, 2010 (SCI-Expanded, Scopus, TRDizin)
2010
2010139. Concomitant renal cell carcinoma and lymphoid malignancies: a case series of five patients and review of the literature
Serefhanoglu S., BÜYÜKAŞIK Y., GÖKER H., Akin S. C., Akin S., SAYINALP N., et al.
MEDICAL ONCOLOGY
, cilt.27, sa.1, ss.55-58, 2010 (SCI-Expanded, Scopus)
2010
2010140. DISEASE CHARACTERISTICS AND FACTORS INFLUENCING TREATMENT RESPONSE IN NEWLY DIAGNOSED ACUTE MYELOBLASTIC LEUKEMIA PATIENTS: A SINGLE CENTER EXPERIENCE
Serefhanoglu S., BÜYÜKAŞIK Y., AKSU S., GÖKER H., SAYINALP N., Cetiner D., et al.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI
, cilt.73, sa.3, ss.74-79, 2010 (ESCI, TRDizin)
2010
2010141. Spinal Myeloid Sarcoma in Two Non-Leukemic Patients
Serefhanoglu S., GÖKER H., AKSU S., BÜYÜKAŞIK Y., SAYINALP N., HAZNEDAROĞLU İ. C., et al.
INTERNAL MEDICINE
, cilt.49, sa.22, ss.2493-2497, 2010 (SCI-Expanded, Scopus)
2010
2010142. Dasatinib-Induced Tumor Lysis Syndrome and Following Hematologic Remission in Fibrotic Blastic Crisis of CML
BEKTAŞ Ö., HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y., SAYINALP N., AKSU S., GÖKER H., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.20, sa.2, ss.13-16, 2010 (SCI-Expanded, Scopus, TRDizin)
2009
2009143. Changes in vascular endothelial growth factor, angiopoietins, and Tie-2 levels with G-CSF stimulation in healthy donors
Serefhanoglu S., GÖKER H., BÜYÜKAŞIK Y., Turgut M., SAYINALP N., HAZNEDAROĞLU İ. C., et al.
ANNALS OF HEMATOLOGY
, cilt.88, sa.7, ss.667-671, 2009 (SCI-Expanded, Scopus)
2009
2009144. Transformation of Adult Myelodysplastic Syndrome-Refractory Anemia to Acute T-Cell Lymphoblastic Leukemia
Serefhanoglu S., GÖKER H., BÜYÜKAŞIK Y., SAYINALP N., ÖZCEBE O. İ.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
, cilt.101, sa.4, ss.370-372, 2009 (SCI-Expanded, Scopus)
2009
2009145. Biphenotypic Acute Leukemia Treated With Acute Myeloid Leukemia Regimens: A Case Series
Serefhanoglu S., BÜYÜKAŞIK Y., GÖKER H., SAYINALP N., ÖZCEBE O. İ.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
, cilt.101, sa.3, ss.270-272, 2009 (SCI-Expanded, Scopus)
2009
2009146. Multiple Bulky Cutaneous Plasmacytomas with CNS Relapse without Bone Marrow Involvement during the Course of a Lambda Light Chain Myeloma
Serefhanoglu S., HAZNEDAROĞLU İ. C., GÖKER H., BÜYÜKAŞIK Y., ÖZCEBE O. İ.
ONKOLOGIE
, cilt.32, sa.11, ss.662-664, 2009 (SCI-Expanded, Scopus)
2008
2008147. Extramedullary plasmacytomas of the thyroid and pericardium as initial presentation of multiple myeloma
Serefhanoglu S., SAYINALP N., HAZNEDAROĞLU İ. C., GÖKER H., Cetiner D., AKSU S., et al.
ANNALS OF HEMATOLOGY
, cilt.87, sa.10, ss.853-854, 2008 (SCI-Expanded, Scopus)
2008
2008148. Effect of platelet count on secretion capacity: formulization and use of the formulae for evaluation of platelet secretion in thrombocytopenic patients
BÜYÜKAŞIK Y., GÖKER H., Buyukasik N. S., SAYINALP N., HAZNEDAROĞLU İ. C., Ozcebea O. I.
BLOOD COAGULATION & FIBRINOLYSIS
, cilt.19, sa.7, ss.633-637, 2008 (SCI-Expanded, Scopus)
2008
2008149. JAK2V617F mutation in patients with portal vein thrombosis
BAYRAKTAR Y., HARMANCI Ö., BÜYÜKAŞIK Y., Shorbagi A. I., Sungur A. H., Boylu C. A., et al.
DIGESTIVE DISEASES AND SCIENCES
, cilt.53, sa.10, ss.2778-2783, 2008 (SCI-Expanded, Scopus)
2008
2008150. Copper deficiency with increased hematogones mimicking refractory anemia with excess blasts
Koca E., BÜYÜKAŞIK Y., Cetiner D., Yimaz R., Sayinalp N., Yasavul U., et al.
LEUKEMIA RESEARCH
, cilt.32, sa.3, ss.495-499, 2008 (SCI-Expanded, Scopus)
2008
2008151. Evidence for higher red blood cell mass in persons with unconjugated Hyperbilirubinemia and Gilbert's syndrome
BÜYÜKAŞIK Y., Akman U., Buyukasik N. S., GÖKER H., Kilicarslan A., Shorbagi A. I., et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES
, cilt.335, sa.2, ss.115-119, 2008 (SCI-Expanded, Scopus)
2008
2008152. Soluble platelet glycoprotein V in distinct disease states of pathological thrombopoiesis
Acar K., AKSU S., Beyazit Y., HAZNEDAROĞLU İ. C., Koca E., Cetiner D., et al.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
, cilt.100, sa.1, ss.86-90, 2008 (SCI-Expanded, Scopus)
2008
2008153. Congenital dysgranulopoietic neutropenia
Olcay L., Yetgin S., Erdernli E., Germeshausen M., Aktas D., Buyukasik Y., et al.
PEDIATRIC BLOOD & CANCER
, cilt.50, sa.1, ss.115-119, 2008 (SCI-Expanded, Scopus)
2007
2007154. The etiologic distribution of thrombophilic factors in chronic portal vein thrombosis
Harmanci O., Ersoy O., Gurgey A., Buyukasik Y., Gedikoglu G., Balkanci F., et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY
, cilt.41, sa.5, ss.521-527, 2007 (SCI-Expanded, Scopus)
2007
2007155. Chemotherapy and imatinib-induced molecular remission in lymphoid blast crisis after 20 years of "untreated" chronic myeloid leukemia
Koca E., Sevimli F., Cetiner D., Haznedaroglu I. C., Sayinalp N., Buyukasik Y., et al.
AMERICAN JOURNAL OF HEMATOLOGY
, cilt.82, sa.4, ss.333, 2007 (SCI-Expanded, Scopus)
2007
2007156. Research for bleeding tendency in patients presenting with significant epistaxis
Dizdar O., Onal I. K., Ozakin E., Karakilic E., Karadag O., Kalyoncu U., et al.
BLOOD COAGULATION & FIBRINOLYSIS
, cilt.18, sa.1, ss.41-43, 2007 (SCI-Expanded, Scopus)
2006
2006157. Successful plasma exchange treatment in hemolytic crisis of Wilson's disease preventing liver transplantation
Harmanci O., Buyukasik Y., Bayraktar Y.
DIGESTIVE DISEASES AND SCIENCES
, cilt.51, sa.7, ss.1230, 2006 (SCI-Expanded, Scopus)
2006
2006158. Does endothelium agree with the concept of idiopathic hepatic vessel thrombosis?
Harmanci O., Buyukasik Y., Kirazli S., Balkanci F., Bayraktar Y.
WORLD JOURNAL OF GASTROENTEROLOGY
, cilt.12, sa.8, ss.1273-1277, 2006 (SCI-Expanded, Scopus)
2005
2005159. No alteration in the PFA-100 in vitro bleeding time induced by the Ginkgo biloba special extract, EGb 761, in elderly patients with mild cognitive impairment
Halil M. G., CANKURTARAN M., YAVUZ B., OZKAYAR N., ULGER Z., DEDE D., et al.
BLOOD COAGULATION & FIBRINOLYSIS
, cilt.16, sa.5, ss.349-353, 2005 (SCI-Expanded, Scopus)
2002
2002160. Treatment of hepatitis B re-activation in lymphoma with lamivudine: A case report and review of the literature Lenfoma seyrinde hepatit B reaktivasyonunun lamivudin ile tedavisi: Bir olgu sunumu ve literatürün gözden geçirilmesi
CANKURTARAN M., ŞİMŞEK H., BÜYÜKAŞIK Y., Tatar G.
THOD - Turk Hematoloji-Onkoloji Dergisi
, cilt.12, sa.1, ss.40-44, 2002 (Scopus, TRDizin)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2020
20201. Saf Eritroid Aplazi ile Seyreden Geç Başlangıçlı ADA2 Eksikliği
SOYAK AYTEKİN E., TAN Ç., ÇAĞDAŞ AYVAZ D. N., BÜYÜKAŞIK Y., TEZCAN F. İ.
6. KLİNİK İMMÜNOLOJİ KONGRESİ, Türkiye, 31 - 01 Ekim 2020, (Özet Bildiri)
2019
20192. STAT3-mediated atypical IFN-gamma signaling modulates the PD-1 ligands in CD11b-positive subpopulation of MDS and AML cells
Yoyen-Ermis D., Tunali G., Tavukcuoglu E., Ozkazanc D., Sutlu T., BÜYÜKAŞIK Y., et al.
17th International Congress of Immunology of the International-Union-of-Immunological-Societies (IUIS), Beijing, Çin, 19 - 23 Ekim 2019, cilt.49, ss.90, (Özet Bildiri)
2019
20193. AZACYTIDINE BEFORE ALLOGENEIC STEM CELL TRANSPLANTATION IS INFERIOR TO HD/ARA-C WITHRESPECT TO RELAPSE FOLLOWING TRANSPLANTATION
DEMİROĞLU H., OKAY M., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., GÜL Ö., BÜYÜKAŞIK Y., et al.
24th EHA Congress, 13 - 16 Haziran 2019, cilt.3, ss.941-942, (Özet Bildiri)
2019
20194. THE EVALUATION OF THE CLINICOPATHOLOGIC CHARACTERISTICS OF T-CELL NON-HODGKIN’S LYMPHOMA: THE SINGLE CENTER EXPERIENCE
SAYINALP N., ALADAĞ KARAKULAK E., OKAY M., ÇİFTÇİLER R., AKSU S., DEMİROĞLU H., et al.
15th International Conference on Malignant Lymphoma, İsviçre, 18 - 22 Haziran 2019, cilt.37, ss.366, (Özet Bildiri)
2019
20195. ALLOJENİK KÖK HÜCRE NAKLİ SONRASI RELAPS İZLENEN AKUT LÖSEMİ HASTALARINDA TEDAVİ SEÇENEKLERİ: DONÖR LENFOSİT İNFUZYONU VE İKİNCİ ALLOJENİK KÖK HÜCRE NAKLİNİN KARŞILAŞTIRILMASI
ALADAĞ KARAKULAK E., DEMİROĞLU H., BÜYÜKAŞIK Y., OKAY M., ÇİFTÇİLER R., SAYINALP N., et al.
4. ULUSAL KAN VE KEMİK İLİĞİ NAKLİ KONGRESİ, Kıbrıs (Kktc), 4 - 06 Nisan 2019, (Özet Bildiri)
2019
20196. HEMATOLOJİK MALİGNİTELERDE DONÖR LENFOSİT İNFÜZYONU ÖNCESİ VERİLEN KEMOTERAPİ SİKLUS SAYISININ SAĞKALIMA ETKİSİ
ALADAĞ KARAKULAK E., OKAY M., ÇİFTÇİLER R., BÜYÜKAŞIK Y., GÖKER H., DEMİROĞLU H.
4. ULUSAL KAN VE KEMİK İLİĞİ NAKLİ KONGRESİ, Kıbrıs (Kktc), 4 - 06 Nisan 2019, (Özet Bildiri)
2019
20197. MULTİPLE MYELOM HASTALARINDA İNDUKSİYON TEDAVİ SÜRESİNİN SAĞKALIMA ETKİSİ
ALADAĞ KARAKULAK E., OKAY M., ÇİFTÇİLER R., DEMİROĞLU H., AKSU S., BÜYÜKAŞIK Y., et al.
3. HEMATOLOJİK İMMUNOLOJİ KONGRESİ, Türkiye, 8 - 09 Mart 2019, (Özet Bildiri)
2018
20188. Long-Term Results of Non-Fludarabine Versus Fludarabine-Based Conditioning Regimens in Severe Aplastic Anemia Patients
ALADAĞ KARAKULAK E., DEMİROĞLU H., Ciftciler R., BÜYÜKAŞIK Y., SAYINALP N., AKSU S., et al.
60th Annual Meeting of the American-Society-of-Hematology (ASH), California, Amerika Birleşik Devletleri, 1 - 04 Aralık 2018, cilt.132, (Özet Bildiri)
2018
20189. AĞIR APLASTİK ANEMİ HASTALARINDA HEMATOPOETİK KÖK HÜCRE NAKLİNDE KULLANILAN HAZIRLIK REJİMLERİNİN KARŞILAŞTIRILMASI
ALADAĞ KARAKULAK E., DEMİROĞLU H., ÇİFTÇİLER R., BÜYÜKAŞIK Y., SAYINALP N., AKSU S., et al.
44.ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 31 Ekim - 03 Kasım 2018, ss.261, (Özet Bildiri)
2018
201810. PHILADELPHIA KROMOZOMU POZİTİF AKUT MYELOİD LÖSEMİLİ OLGU
DEMİROĞLU H., GÖKER H., BÜYÜKAŞIK Y., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., OKAY M.
TÜRK HEMATOLOJİ DERNEĞİ, Türkiye, 31 Ekim - 03 Kasım 2018, (Tam Metin Bildiri)
2018
201811. MRG’DE TESADÜFEN SAPTANAN KEMİK İLİĞİNİN DİFFÜZ SİNYAL DEĞİŞİKLİKLERİ LENFOHEMATOPOETİK HASTALIKLARI ÖNGÖREBİLİR Mİ?
ÇİFTÇİLER R., ALADAĞ KARAKULAK E., AKSU S., SAYINALP N., DEMİROĞLU H., GÖKER H., et al.
44. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 31 Ekim - 03 Kasım 2018, ss.266, (Özet Bildiri)
2018
201812. PHİLADELPHİA KROMOZOMU POZİTİF AKUT MYELOİDLÖSEMİLİ OLGU
ÇİFTÇİLER R., ALADAĞ KARAKULAK E., OKAY M., GÖKER H., DEMİROĞLU H., BÜYÜKAŞIK Y.
44. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 31 Ekim - 03 Kasım 2018, ss.340, (Özet Bildiri)
2018
201813. T HÜCRELİ LENFOMA HASTALARININ KLİNİK ÖZELLİKLERİNİN DEĞERLENDİRİLMESİ: TANIDAN PROGNOZA TEK MERKEZ DENEYİMİ
DEMİROĞLU H., SAYINALP N., GÖKER H., BÜYÜKAŞIK Y., ÖZCEBE O. İ., HAZNEDAROĞLU İ. C., et al.
TÜRK HEMATOLOJİ DERNEĞİ, Türkiye, 31 Ekim - 03 Kasım 2018, (Tam Metin Bildiri)
2018
201814. LENALIDOMID İLE MYELOMDA OTOLOG NAKİL SONRASI İLK NÜKSDE TALİDOMİD VE BORTEZOMİBE KIYASLA DAHA İYİ İLERLEMESİZ SAĞKALIM
DEMİROĞLU H., AKSU S., SAYINALP N., GÖKER H., BÜYÜKAŞIK Y., ÖZCEBE O. İ., et al.
TÜRK HEMATOLOJİ DERNEĞİ, Türkiye, 31 Ekim - 03 Kasım 2018, (Tam Metin Bildiri)
2018
201815. DASATİNİB KULLANIRKEN PLEVRAL EFFÜZYONU GELİŞİP, KÜÇÜK HÜCRELİ AKCİĞER KANSERİ TANISI ALAN BİR OLGU
ÇİFTÇİLER R., ALADAĞ KARAKULAK E., SAYINALP N., HAZNEDAROĞLU İ. C., ÖZCEBE O. İ., AKSU S., et al.
44. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 31 Ekim - 03 Kasım 2018, ss.364-365, (Özet Bildiri)
2018
201816. LENALİDOMİD İLE MYELOMDA OTOLOG NAKİL SONRASI İLK NÜKSDE TALİDOMİD VE BORTEZOMİB’E KIYASLA DAHA İYİ İLERLEMESİZ SAĞKALIM
MALKAN Ü. Y., BÜYÜKAŞIK Y., DEMİROĞLU H., ÇİFTÇİLER R., GÜNEŞ G., OKAY M., et al.
44.ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 31 Ekim - 03 Kasım 2018, ss.191-192, (Özet Bildiri)
2018
201817. BRENTIXUMAB VEDOTIN IN CD30 LYMPHOMAS: SINGLE CENTER EXPERIENCE
DEMİROĞLU H., SAYINALP N., BÜYÜKAŞIK Y., ÖZCEBE O. İ., HAZNEDAROĞLU İ. C., GÖKER H., et al.
IX. INTERNATIONAL EHOC, 17 - 20 Ekim 2018, cilt.73, (Tam Metin Bildiri)
2018
201818. Descriptive analysis of myeloproliferative diseases and its complications
OKAY M., MALKAN Ü. Y., BÖLEK E. Ç., Aladag E., HAZIYEV T., SAYINALP N., et al.
9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 17 - 20 Ekim 2018, cilt.73, (Özet Bildiri)
2018
201819. Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma
OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., MALKAN Ü. Y., CIFTCILER R., Aladag E., et al.
9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 17 - 20 Ekim 2018, cilt.73, (Özet Bildiri)
2018
201820. RELAPS/REFRAKTER LENFOMADA OTOLOG KÖK HÜCRE TRANSPLANTASYONUNDA MİTOKSANNTRON-MELFALAN HAZIRLAMA REJİMİ
OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., malkan Ü. Y., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., et al.
6. HEMATOLOJİK ONKOLOJİ KONGRESİ, Türkiye, 18 - 22 Eylül 2018, (Tam Metin Bildiri)
2018
201821. RELAPS/REFRAKTER LENFOMADA OTOLOG KÖK HÜCRE TRANSPLANTASYONUNDA MİTOKSANTRON-MELFALAN HAZIRLAMA REJİMİ
OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., MALKAN Ü. Y., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., et al.
5. HEMATOLOJİK ONKOLOJİ KONGRESİ, Kıbrıs (Kktc), 20 - 22 Eylül 2018, (Özet Bildiri)
2018
201822. AKUT MYELOİD LÖSEMİLİ BİR OLGULDA SİTOZİN ARABİNOZİD İLİŞKİLİ PULMONER TOKSİSİTE
ÇİFTÇİLER R., ALADAĞ KARAKULAK E., HAZNEDAROĞLU İ. C., AKSU S., DEMİROĞLU H., GÖKER H., et al.
4.İLAÇ VE TEDAVİ KONGRESİ, Kıbrıs (Kktc), 19 - 23 Eylül 2018, ss.254, (Özet Bildiri)
2018
201823. COMPARISON OF MYELOABLATIVE AND REDUCED-INTENSITY CONDITIONING REGIMENS FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
ÇİFTÇİLER R., OKAY M., ALADAĞ KARAKULAK E., BÜYÜKAŞIK Y., GÖKER H., DEMİROĞLU H.
EUROPEAN HEMATOLOGY ASSOCIATION, 14 - 17 Haziran 2018, (Tam Metin Bildiri)
2018
201824. EFFECT OF THE INDUCTION THERAPY ON SURVIVAL IN MULTIPLE MYELOMA PATIENTS
ALADAĞ KARAKULAK E., ÇİFTÇİLER R., DEMİROĞLU H., AKSU S., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., et al.
The International Congress of BMT 2018, Busan, Güney Kore, 30 Ağustos - 01 Eylül 2018, (Özet Bildiri)
2018
201825. Compliance to the guideline of diagnostic tests in febrile neutropenic patients at a Turkish university hospital’
ZARAKOLU KÖŞKER I. P., AKOVA M., BÜYÜKAŞIK Y., DURUSU TANRIÖVER M., DİZDAR Ö., METAN G., et al.
20th Symposium on Infections in the immunocompromised host, Atina, Yunanistan, 17 - 19 Haziran 2018, (Tam Metin Bildiri)
2018
201826. Posttransplant Ebstain-Barr viral load monitoring experience in a hematopoietic stem cell transplantation center
AYDIN M. S., Inkaya Çağkan a., ALADAĞ KARAKULAK E., çiftçiler R., TURGUT M., GÖKER H., et al.
European Hematology Association, 14 - 17 Haziran 2018, (Özet Bildiri)
2018
201827. RISK FACTORS FOR EARLY MORTALITY IN MULTIPLE MYELOMA WITH DIFFERENT SURVIVAL TIME CUT-OFF POINTS: REAL-LIFE DATA
AYDIN M. S., ALADAĞ KARAKULAK E., ÇİFTÇİLER R., DEMİROĞLU H., GÖKER H., TURGUT M., et al.
23rd Congress of EHA, Stockholm, İsveç, 14 - 17 Haziran 2018, (Özet Bildiri)
2018
201828. POST-TRANSPLANT EBSTEIN-BARR VIRAL LOAD MONITORING EXPERIENCE IN A HEMATOPOIETIC STEM CELL TRANSPLANTATION CENTER
AYDIN M. S., İNKAYA A. Ç., ALADAĞ KARAKULAK E., ÇİFTÇİLER R., TURGUT M., GÖKER H., et al.
23rd Congress of EHA, Stockholm, İsveç, 14 - 17 Haziran 2018, (Özet Bildiri)
2018
201829. ANJİMMUNOBLASTİK T HÜCRELİ LENFOMA, ÇOK YÜZLÜ LENFOMA
OKAY M., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., HEZİYEV T., GÖKER H., BÜYÜKAŞIK Y.
2. HEMATOLOJİK İMMUNOLOJİ KONGRESİ, Kıbrıs (Kktc), 4 - 06 Mayıs 2018, (Özet Bildiri)
2018
201830. KRONİK LENFOSİTİK LÖSEMİ HASTALARINDA İKİNCİL MALİGNİTELERİN DEĞERLENDİRİLMESİ
ALADAĞ KARAKULAK E., OKAY M., ÇİFTÇİLER R., HEZİYEV T., BÜYÜKAŞIK Y., SAYINALP N., et al.
2. HEMATOLOJİK İMMUNOLOJİ KONGRESİ, Kıbrıs (Kktc), 4 - 06 Mayıs 2018, (Özet Bildiri)
2018
201831. PLAZMA HÜCRELİ LÖSEMİ ŞEKLİNDE PREZENTE OLAN WALDENSTROM MAKROGOBULİNEMİSİ
ÇİFTÇİLER R., OKAY M., ALADAĞ KARAKULAK E., HEZİYEV T., AKSU S., SAYINALP N., et al.
2. HEMATOLOJİK İMMUNOLOJİ KONGRESİ, Kıbrıs (Kktc), 4 - 06 Mayıs 2018, (Özet Bildiri)
2018
201832. Common medical problems in adult patients with Hemophilia A: A single center experience
AYDIN M. S., OKAY M., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., DEMİROĞLU H., GÖKER H., et al.
15. INTERNATIONAL HEMOPHILIA CONGRESS OF TURKEY, İstanbul, Türkiye, 4 - 07 Nisan 2018, (Özet Bildiri)
2017
201733. Echocardiographic Evaluation of Patients with Hodgkin and Non Hodgkin Lymphoma before and after Hematopoietic Stem Cell Transplantation
KELKİTLİ E., BÜYÜKAŞIK Y., DEMİROĞLU H., ŞAHİNER M. L., OKAY M., AYDIN M. S., et al.
59th ASH, 9 - 12 Aralık 2017, cilt.130, ss.5521, (Özet Bildiri)
2017
201734. Bağışıklık sistemi baskılanmış hastalarda Microsporidia ve fırsatçı bağırsak parazitlerinin varlığının araştırılması
Kaya F., İNKAYA A. Ç., AKSOY S., ABBASOĞLU O., ERTENLİ A. İ., BÜYÜKAŞIK Y., et al.
4. Ulusal Klinik Mikrobiyoloji Kongresi, Türkiye, 8 - 12 Kasım 2017, (Özet Bildiri)
2017
201735. Epidemiological Estimatesand Treatment Practice Pattern in Polycytemia Vera Patients in Turkey:Results Based on an Expert Panel
BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., ÖZET G., Ar C., Özcan M., Güvenç B., et al.
ISPOR 20th Annual European Congress, 4 - 08 Kasım 2017, (Özet Bildiri)
2017
201736. The Modelled Effetiveness oh Ruxolitinib on survival in PV Patients with Hydroxyurea Resistance /Intolerancein Turkey
BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., ÖZET G., Ar C., Özcan M., Güvenç B., et al.
ISPOR 20th Annual Eurepean Congress, 4 - 08 Kasım 2017, (Özet Bildiri)
2017
201737. Erken Evre Kronik Lenfositer Löseminin Nadir Görünümleri ve Bir Mide Kanseri Vakası Birlikteliği: 2 vaka sunumu.
AYDIN M. S., ÜNER A., OKAY M., MALKAN Ü. Y., BÜYÜKAŞIK Y., ÖZCEBE O. İ., et al.
43. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 31 Ekim - 05 Kasım 2017, cilt.1, ss.66, (Özet Bildiri)
2017
201738. Prognosis of Multiple Myeloma in Younger Patients who Undergoing Upfront Autologous Stem Cell Transplantation
KELKİTLİ E., GÖKER H., demiroglu H., TURGUT M., SAYINALP N., AKSU S., et al.
LYMPHOMA MYELOMA 2017, 26 - 28 Ekim 2017, (Özet Bildiri)
2017
201739. Monoclonhal gammopathy of renal significance presenting as monotypic plasma cell interststial nephritis in two patients with Sjogren’xxs Syndrome
Balaban S., AYHAN E. A., ÜNER A., OKAY M., BÜYÜKAŞIK Y.
7. Uluslararası Avrasya Hematoloji Kongresi, 13 - 16 Ekim 2017, cilt.61, ss.15, (Özet Bildiri)
2017
201740. RARE PRESENTATIONS OF EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA AND A COINCIDENCE WITH GASTRIC CANCER: 2 CASES
AYDIN M. S., ÜNER A., malkan Ü. Y., OKAY M., BÜYÜKAŞIK Y., ÖZCEBE O. İ., et al.
LEUKEMIA RESEARCH, İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, ss.16, (Özet Bildiri)
2017
201741. MONOCLONAL GAMMOPATHY OF RENAL SIGNIFICANCE PRESENTING AS MONOTYPIC PLASMA CELL INTERTISTIAL NEPHRITIS IN TWO PATIENTS WITH SJÖGREN’S SYNDROME
AYDIN M. S., sağlam a., ÜNER A., OKAY M., BÜYÜKAŞIK Y.
VIII.EURASIAN HEMATOLOGY ONCOLOGY CONGRESS, İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, ss.16, (Özet Bildiri)
2018
201842. EFFECT OF INDUCTION THERAPY ON SURVIVAL IN MULTIPLE MYELOMA PATIENTS
DEMİROĞLU H., ALADAĞ KARAKULAK E., AKSU S., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., SAYINALP N., et al.
INTERNATIONAL CONGRESS OF BMT 2018, Busan, Güney Kore, 30 Ağustos - 01 Eylül 2018, cilt.53, (Tam Metin Bildiri)
2017
201743. The Impact of Chemo/Immune Therapy-‐Related Cytopeniason the Clinical Course of Chronic Lymphoid Leukemia
OKAY M., HAZNEDAROĞLU İ. C., malkan Ü. Y., GÜNEŞ G., aslan n., AKSU S., et al.
iwcll2017, New York, Amerika Birleşik Devletleri, 12 - 15 Mayıs 2017, (Özet Bildiri)
2017
201744. Kemoterapiye refrakter primer mediastinal granülositik sarkom hastasının allojeneik kök hücre transplantasyonu ile tedavisi
ETGÜL S., MALKAN Ü. Y., TURGUT M., DEMİROĞLU H., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., et al.
2. Hematolojik Onkoloji Kongresi, Kıbrıs (Kktc), 16 - 19 Şubat 2017, (Özet Bildiri)
2016
201645. Costimulatory signals derived from myeloid leukemia cells contribute to functional exhaustion in CD4(+) T cells
Ozkazanc D., BÜYÜKAŞIK Y., ESENDAĞLI G.
International Congress of Immunology (ICI), Melbourne, Avustralya, 21 - 26 Ağustos 2016, cilt.46, ss.1092-1093, (Özet Bildiri)
2015
201546. Levofloksasin profilaksisi alan hematolojik kanserli nötropenik hastalarda kinolon dirençli Escherichia coli sürveyansı
ETGÜL S., ZARAKOLU KÖŞKER I. P., ESER Ö., KARA Ö., BÜYÜKAŞIK Y., Akova M.
3. Ulusal Klinik Mikrobiyoloji Uzmanlık Derneği Kongresi, Türkiye, 18 - 22 Kasım 2015, (Tam Metin Bildiri)
2015
201547. BLEOMYCIN-INDUCED INTERSTITIAL LUNG DISEASE: A CASE REPORT
Malkan Ü. Y., GÜNEŞ G., Aslan T., AKSU S., HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)
2015
201548. THE COEXISTENCE OF B-THALASSEMIA MINOR AND SICKLE CELL ANEMIA: A CASE REPORT
Malkan Ü. Y., GÜNEŞ G., ELİAÇIK E., Yayar O., DEMİROĞLU H., BÜYÜKAŞIK Y.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)
2015
201549. PRE-EMPTIVE USAGE OF RITUXIMAB IN A THROMBOTIC THROMBOCYTOPENIC PURPURA CASE
Yayar O., Malkan Ü. Y., Gunes G., Buyukasik Y.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)
2015
201550. Adrenal insufficiency due to antiphospholipid syndrome in a patient with MTHFR
ŞENER Y. Z., ÖZIŞIK L., ERDEN A., KALYONCU U., DURUSU TANRIÖVER M., BÜYÜKAŞIK Y., et al.
14 th Congress European Federation of Internal Medicine, Moskva, Rusya, 14 - 16 Ekim 2015, ss.328-329
2015
201551. GENERIC IMATINIB MESYLATE IS AS EFFECTIVE AS ORIGINAL GLIVEC IN THE MANAGEMENT OF CML
AKSU S., Aktimur S. H., Arica D. C., Atay H., Bektas O., BÜYÜKAŞIK Y., et al.
20th Congress of European-Hematology-Association, Vienna, Avusturya, 11 - 14 Haziran 2015, cilt.100, ss.690, (Özet Bildiri)
2015
201552. Extramedullary relapses after allogeneic stem cell transplantation for leukemia: Clinical characteristics, cumulative incidence and risk factors
Goker H., Gunes G., Demiroglu H., Malkan Ü. Y., Haznedaroglu I., Sayinalp N., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)
2014
201453. Prognostic Factors for Survival of Elderly Patients with Acute Myeloid Leukemia after Intensive Chemotherapy: Validation of 3 Popular Prognostic Models
Koca E., Halacoglu A., Malkan Ü. Y., Arica D., Karakus S., GÖKER H., et al.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124, (Özet Bildiri)
2014
201454. Lower Doses of Plerixafor Use Is Sufficient to Effectively Mobilize PBSC (Peripheral Blood Hematopoetic Stem Cells) When Compared to Standard Administration
GÖKER H., ELİAÇIK E., Altuntas F., Tekgunduz E., ÖZDEMİR E., Isik A., et al.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124, (Özet Bildiri)
2014
201455. Treatment resistant autoimmune autonomic ganglionitis associated with increased serum immunoglobulin light chains
Vural A., Senol P. N., BÜYÜKAŞIK Y., ELİBOL B., TUNCER M. A.
12th International Congress of Neuroimmunology (ISNI), Mainz, Almanya, 9 - 13 Kasım 2014, cilt.275, ss.47, (Özet Bildiri)
2014
201456. GENERIC IMATINIB MESYLATE IS AS EFFECTIVE AS ORIGINAL GLIVEC IN THE MANAGEMENT OF CML
AKSU S., AKTİMUR S., ARİCA D., ATAY M. H., BEKTAŞ Ö., BÜYÜKAŞIK Y., et al.
20th Congress of the European Hematology Association Vienna, Austria June 11-14,2015, 11 - 14 Haziran 2014, (Tam Metin Bildiri)
2014
201457. High-dose chemotherapy and autologons peripheral blood stein tell (PBSC) transplantation with initt-cryopreserved PBSCs in multiple myeloma
Goker H., Eliacik E., Buyukasik Y., Haznedaroglu I. C., Turgut M., Aksu S., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)
2013
201358. Transfüzyon ilişkili graft versus host hastalığı
Erkuş B., ÖZIŞIK L., HELVACI Ö., ORTAÇ ERSOY N. E., DURUSU TANRIÖVER M., BÜYÜKAŞIK Y., et al.
10. Ulusal Dahili ve Cerrahi Bilimler Yoğun Bakım Kongresi, İstanbul, Türkiye, 27 - 30 Kasım 2013, ss.64
2013
201359. Philadelphia-positive acute lymphoblastic leukemia in daily practice: A multicenter experience.
Goker H., Tekgunduz E., Sari I., Pala C., Dogu M. H., Ozturk E., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)
2006
200660. Pyrimidine 5' nucleotidase-1 (P5N-1) deficiency associated with 4 novel mutations in 5 new Turkish families: Genotype-phenotype analysis.
Balta G., Gurgey A., Gumruk F., Buyukasik Y., Beksac M., Altay C.
48th Annual Meeting of the American-Society-of-Hematology, Florida, Amerika Birleşik Devletleri, 9 - 12 Aralık 2006, cilt.108, (Özet Bildiri)
Kitaplar
2019
20191. Klinik Pratikte Hematoloji
HAZNEDAROĞLU İ. C., TURGUT M., GÖKER H., BÜYÜKAŞIK Y.
nobel tıp kitabevleri, Ankara, 2019
Desteklenen Projeler
2021 - 2023
2021 - 2023Allojeneik Kök Hücre Nakli Yapılan Akut Myeloid Lösemi Hastalarında Nakil Öncesi Rezidüel Hastalık Varlığının ve Hazırlama Rejimi Seçiminin Nakil Sonuçlarına Etkisi
Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi
BÜYÜKAŞIK Y. (Yürütücü), KORKUT M. G., SAYINALP B., ÖZMEN F.
2018 - 2021
2018 - 2021AML Tedavisinde Kullanılan Idarubisin ve Sitarabin Ajanlarının NK Hücreleri Üzerindeki Fenotipik ve Fonksiyonel Etkilerinin İncelenmesi
Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi
ÖZMEN F. (Yürütücü), OKAY M., Aydın B., Çelik E. Ç., BÜYÜKAŞIK Y.
2018 - 2020
2018 - 2020Trombositopenik hastalarda platelet yüzey antijenlerinin flow sitometri ile incelenmesi ve kanama diyatezi ile ilişkisinin araştırılması
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
DİKMEN Z. G. (Yürütücü), BAKIR E. N., KILIÇKAP S., ÇİFTÇİLER R., BÜYÜKAŞIK Y., KARAHAN S.
2015 - 2017
2015 - 2017Tirozin kinaz inhibitörlerini kullanan Kronik Myeloid Lösemi hastalarında trombosit fonksiyonlarının değerlendirilmesi
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
DİKMEN Z. G. (Yürütücü), BÜYÜKAŞIK Y., AYDIN M. S., ŞENER Y., AKBIYIK F.